AGT and COVID-19: Consistent with this hypothesis, a cohort of 12 patients with COVID-19 showed an increase in circulating Ang II levels compared to healthy individuals, suggesting a possible link between the downregulation of tissue ACE2, a systemic imbalance of RAS, and an increased risk of multi-organ damage from SARS-CoV-2 infection [48].